Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window
Abstract
1. Introduction
2. Methods
2.1. Patient Selection
2.2. Statistical Methodology
Data Analyses
3. Results
3.1. Patient Cohort Characteristics and Outcomes
3.2. Predictors of Favorable Outcomes
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Feigin, V.L.; Stark, B.A.; Johnson, C.O.; Roth, G.A.; Bisignano, C.; Abady, G.G.; Abbasifard, M.; Abbasi-Kangevari, M.; Abd-Allah, F.; Abedi, V.; et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021, 20, 795–820. [Google Scholar] [CrossRef] [PubMed]
- Fransen, P.S.; Beumer, D.; Berkhemer, O.A.; van den Berg, L.A.; Lingsma, H.; van der Lugt, A.; van Zwam, W.H.; van Oostenbrugge, R.J.; Roos, Y.B.; Majoie, C.B.; et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: Study protocol for a randomized controlled trial. Trials 2014, 15, 343. [Google Scholar] [CrossRef] [PubMed]
- Powers, W.J.; Derdeyn, C.P.; Biller, J.; Coffey, C.S.; Hoh, B.L.; Jauch, E.C.; Johnston, K.C.; Johnston, S.C.; Khalessi, A.A.; Kidwell, C.S.; et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke 2015, 46, 3020–3035. [Google Scholar] [CrossRef] [PubMed]
- Goyal, M.; Menon, B.K.; van Zwam, W.H.; Dippel, D.W.; Mitchell, P.J.; Demchuk, A.M.; Dávalos, A.; Majoie, C.B.; van der Lugt, A.; de Miquel, M.A.; et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 2016, 387, 1723–1731. [Google Scholar] [CrossRef] [PubMed]
- Albers, G.W.; Marks, M.P.; Kemp, S.; Christensen, S.; Tsai, J.P.; Ortega-Gutierrez, S.; McTaggart, R.A.; Torbey, M.T.; Kim-Tenser, M.; Leslie-Mazwi, T.; et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N. Engl. J. Med. 2018, 378, 708–718. [Google Scholar] [CrossRef]
- Nogueira, R.G.; Jadhav, A.P.; Haussen, D.C.; Bonafe, A.; Budzik, R.F.; Bhuva, P.; Yavagal, D.R.; Ribo, M.; Cognard, C.; Hanel, R.A.; et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2018, 378, 11–21. [Google Scholar] [CrossRef] [PubMed]
- Almallouhi, E.; Al Kasab, S.; Hubbard, Z.; Bass, E.C.; Porto, G.; Alawieh, A.; Chalhoub, R.; Jabbour, P.M.; Starke, R.M.; Wolfe, S.Q.; et al. Outcomes of Mechanical Thrombectomy for Patients With Stroke Presenting With Low Alberta Stroke Program Early Computed Tomography Score in the Early and Extended Window. JAMA Netw. Open 2021, 4, e2137708. [Google Scholar] [CrossRef] [PubMed]
- Broocks, G.; Hanning, U.; Bechstein, M.; Elsayed, S.; Faizy, T.D.; Brekenfeld, C.; Flottmann, F.; Kniep, H.; Deb-Chatterji, M.; Schön, G.; et al. Association of Thrombectomy With Functional Outcome for Patients With Ischemic Stroke Who Presented in the Extended Time Window With Extensive Signs of Infarction. JAMA Netw. Open 2022, 5, e2235733. [Google Scholar] [CrossRef]
- O’Connor, K.P.; Hathidara, M.Y.; Danala, G.; Xu, C.; McCoy, T.M.; Sidorov, E.V.; Zheng, B.; Bohnstedt, B.N.; Ray, B. Predicting Clinical Outcome After Mechanical Thrombectomy: The GADIS (Gender, Age, Diabetes Mellitus History, Infarct Volume, and Sex) Score. World Neurosurg. 2020, 134, e1130–e1142. [Google Scholar] [CrossRef] [PubMed]
- Butler, J.; Heidari, P.; Blayney, S.; Hitomi, E.; Luby, M.; Leigh, R. Blood-brain barrier integrity of stroke patients presenting in an extended time window. BMC Neurol. 2020, 20, 54. [Google Scholar] [CrossRef] [PubMed]
- Jovin, T.G.; Nogueira, R.G.; Lansberg, M.G.; Demchuk, A.M.; Martins, S.O.; Mocco, J.; Ribo, M.; Jadhav, A.P.; Ortega-Gutierrez, S.; Hill, M.D.; et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): A systematic review and individual patient data meta-analysis. Lancet 2022, 399, 249–258. [Google Scholar] [CrossRef] [PubMed]
- Sarraj, A.; Hassan, A.E.; Abraham, M.G.; Ortega-Gutierrez, S.; Kasner, S.E.; Hussain, M.S.; Chen, M.; Blackburn, S.; Sitton, C.W.; Churilov, L.; et al. SELECT2 Investigators. Trial of Endovascular Thrombectomy for Large Ischemic Strokes. N. Engl. J. Med. 2023, 388, 1259–1271. [Google Scholar] [CrossRef] [PubMed]
- Yoshimura, S.; Sakai, N.; Yamagami, H.; Uchida, K.; Beppu, M.; Toyoda, K.; Matsumaru, Y.; Matsumoto, Y.; Kimura, K.; Takeuchi, M.; et al. Endovascular Therapy for Acute Stroke with a Large Ischemic Region. N. Engl. J. Med. 2022, 386, 1303–1313. [Google Scholar] [CrossRef] [PubMed]
- Mourand, I.; Abergel, E.; Mantilla, D.; Ayrignac, X.; Sacagiu, T.; Eker, O.F.; Gascou, G.; Dargazanli, C.; Riquelme, C.; Moynier, M.; et al. Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation stroke. J. Neurointerv. Surg. 2018, 10, 5–9. [Google Scholar] [CrossRef] [PubMed]
- Sarzetto, F.; Gupta, S.; Alotaibi, N.M.; Howard, P.; da Costa, L.; Heyn, C.; Maralani, P.J.; Guha, D.; Swartz, R.H.; Boyle, K.; et al. Outcome Evaluation of Acute Ischemic Stroke Patients Treated with Endovascular Thrombectomy: A Single-Institution Experience in the Era of Randomized Controlled Trials. World Neurosurg. 2017, 99, 593–598. [Google Scholar] [CrossRef] [PubMed]
- Malhotra, K.; Goyal, N.; Katsanos, A.H.; Filippatou, A.; Mistry, E.A.; Khatri, P.; Anadani, M.; Spiotta, A.M.; Sandset, E.C.; Sarraj, A.; et al. Association of Blood Pressure With Outcomes in Acute Stroke Thrombectomy. Hypertension 2020, 75, 730–739. [Google Scholar] [CrossRef] [PubMed]
- Ciurică, S.; Lopez-Sublet, M.; Loeys, B.L.; Radhouani, I.; Natarajan, N.; Vikkula, M.; Maas, A.H.E.M.; Adlam, D.; Persu, A. Arterial Tortuosity. Hypertension 2019, 73, 951–960. [Google Scholar] [CrossRef] [PubMed]
- Nogueira, R.G.; Liebeskind, D.S.; Sung, G.; Duckwiler, G.; Smith, W.S.; MERCI; Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: Pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009, 40, 3777–3783. [Google Scholar] [CrossRef] [PubMed]
Variables | Overall | Favorable | Unfavorable | p |
---|---|---|---|---|
MRS 0–6 | MRS 0–2 | MRS 3–6 | ||
N = 121 | N = 51 | N = 70 | ||
Age, Mean (SD) | 73.4 (14.7) | 68.7 (14.6) | 76.8 (13.9) | 0.002 * |
Age > = 80 | ||||
No | 72 (59.5%) | 37 (72.6%) | 35 (50.0%) | 0.013 * |
Yes | 49 (40.5%) | 14 (27.5%) | 35 (50.0%) | |
Sex (Female) | ||||
Female | 58 (47.9%) | 26 (51.0%) | 32 (45.7%) | 0.567 |
Male | 63 (52.1%) | 25 (49.0%) | 38 (54.3%) | |
Smoking | ||||
Current smoker | 16 (13.2%) | 6 (11.8%) | 10 (14.3%) | 0.463 |
Former smoker | 48 (39.7%) | 22 (43.1%) | 26 (37.1%) | |
Never smoker | 41 (33.9%) | 19 (37.3%) | 22 (31.4%) | |
N/A | 16 (13.2%) | 4 (7.8%) | 12 (17.1%) | |
LOS, Median (IQR) | 6 (3.14–11) | 4.12 (3–7) | 7.20 (4.24–14) | <0.001 * |
Mismatch volume, mean (SD) | 95.467 (49.218) | 93.818 (47.309) | 96.619 (50.852) | 0.774 |
Mismatch volume ≥ 40 | ||||
No | 13 (10.7%) | 6 (11.8%) | 7 (10.0%) | 0.757 |
Yes | 108 (89.3%) | 45 (88.2%) | 63 (90.0%) | |
Symptom onset to er presentation (hour) | 0.329 | |||
Mean (SD) | 10.32 (4.51) | 10.81 (4.83) | 9.96 (4.26) | |
Median (IQR) | 9.92 (6.32–13.06) | 10.37 (6.82–13.75) | 9.78 (6.17–12.75) | |
Symptom onset to reperfusion (hour) | 0.141 | |||
Mean (SD) | 12.60 (4.30) | 13.28 (4.56) | 12.05 (4.04) | |
Median (IQR) | 12.23 (8.77–15.34) | 13.52 (8.92–16.28) | 11.66 (8.60–14.39) | |
Symptom onset to groin puncture (hour) | 0.037 * | |||
Mean (SD) | 11.50 (4.32) | 12.38 (4.43) | 10.82 (4.14) | |
Median (IQR) | 11.23 (7.43–14.12) | 12.08 (8.05–15.50) | 10.01 (6.92–13.03) | |
Symptom onset to groin puncture | ||||
6–<9 h | 41 (35.0%) | 15 (29.4%) | 26 (39.4%) | 0.209 |
9–<12 h | 2 (1.7%) | 0 (0.0%) | 2 (3.0%) | |
12+ h | 74 (63.2%) | 36 (70.6%) | 38 (57.6%) | |
Baseline NIHSS, Median (IQR) | 13.5 (7–20) | 12 (6–17) | 15 (9–21) | 0.014 * |
Site of Occlusion | ||||
ICA | 30 (24.8%) | 9 (17.7%) | 21 (30.0%) | 0.120 |
M1 | 91 (75.2%) | 42 (82.4%) | 49 (70.0%) | |
CBF (cc), Mean (SD) | 17.240 (26.126) | 15.796 (24.053) | 18.30 (27.70) | 0.631 |
CBF | ||||
<10 cc | 62 (51.7%) | 27 (54.0%) | 35 (50.0%) | 0.787 |
10–25 cc | 13 (10.8%) | 6 (12.0%) | 7 (10.0%) | |
>25 cc | 45 (37.5%) | 17 (34.0%) | 28 (40.0%) | |
TICI | ||||
0–2A | 26 (21.5%) | 4 (7.8%) | 22 (31.4%) | 0.002 * |
2B–3 | 95 (78.5%) | 47 (92.2%) | 48 (68.6%) | |
Discharge disposition | ||||
Expired | 13 (10.7%) | 0 (0%) | 13 (18.6%) | <0.001 * |
Home | 33 (27.3%) | 28 (54.9%) | 5 (7.1%) | |
Hospice | 7 (5.8%) | 0 (0%) | 7 (10.0%) | |
Hospital or Rehab | 68 (56.2%) | 23 (45.1%) | 45 (64.3%) | |
In-Hospital Mortality | 10 (8.3%) | 0 (0%) | 10 (14.3%) | 0.005 * |
Atrial fibrillation | ||||
No | 58 (47.9%) | 29 (56.9%) | 29 (41.4%) | 0.093 |
Yes | 63 (52.1%) | 22 (43.1%) | 41 (58.6%) | |
Hypertension | ||||
No | 45 (37.2%) | 26 (51.0%) | 19 (27.1%) | 0.007 * |
Yes | 76 (62.8%) | 25 (49.0%) | 51 (72.9%) | |
Type-2 diabetes | ||||
No | 95 (78.5%) | 42 (82.4%) | 53 (75.7%) | 0.380 |
Yes | 26 (21.5%) | 9 (17.7%) | 17 (24.3%) | |
ASPECTS | ||||
2–5 | 7 (7.0%) | 4 (9.5%) | 3 (5.2%) | 0.449 |
≥6 | 93 (93.0%) | 38 (90.5%) | 55 (94.8%) | |
Dawn [6] | ||||
True | 41 (33.9%) | 17 (33.3%) | 24 (34.3%) | 0.913 |
False | 80 (66.1%) | 34 (66.7%) | 46 (65.7%) | |
Defuse [5] | ||||
True | 39 (32.2%) | 14 (27.5%) | 25 (35.7%) | 0.337 |
False | 82 (67.8%) | 37 (72.6%) | 45 (64.3%) | |
Symptomatic ICH | ||||
No | 116 (95.9%) | 51 (100.0%) | 65 (92.9%) | 0.073 |
Yes | 5 (4.1%) | 0 (0.0%) | 5 (7.1%) | |
EF | 58.972 (13.834) | 58.404 (12.942) | 59.417 (14.587) | 0.709 |
TPA given | ||||
No | 44 (83.0%) | 21 (87.5%) | 23 (79.3%) | 0.488 |
Yes | 9 (17.0%) | 3 (12.5%) | 6 (20.7%) | |
Symptom onset to TPA administration (hour) | 0.154 | |||
Mean (SD) | 3.16 (1.66) | 4.40 (2.48) | 2.85 (1.37Z) | |
Median (IQR) | 3.50 (2.00–4.15) | 3.67 (2.37–7.17) | 3.25 (1.50–4.08) | |
Cervical Carotid involvement | ||||
No | 10 (17.2%) | 5 (20.0%) | 5 (15.2%) | 0.732 |
Yes | 48 (82.8%) | 20 (80.0%) | 28 (84.9%) |
Variables | OR | 95% CI | P |
---|---|---|---|
Baseline NIHSS | 0.92 | 0.87–0.98 | 0.0095 |
mTICI, 2B–3 vs. 0–2A | 7.33 | 2.06–26.07 | 0.0021 |
Hypertension, Yes vs. No | 0.33 | 0.14–0.80 | 0.0135 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Constantakis, J.; Steiner, Q.; Reher, T.; Choi, T.; Hollnagel, F.; Zhao, Q.; Bennett, N.; Nair, V.A.; Adelman, E.E.; Prabhakaran, V.; et al. Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window. J. Clin. Med. 2025, 14, 5556. https://doi.org/10.3390/jcm14155556
Constantakis J, Steiner Q, Reher T, Choi T, Hollnagel F, Zhao Q, Bennett N, Nair VA, Adelman EE, Prabhakaran V, et al. Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window. Journal of Clinical Medicine. 2025; 14(15):5556. https://doi.org/10.3390/jcm14155556
Chicago/Turabian StyleConstantakis, John, Quinn Steiner, Thomas Reher, Timothy Choi, Fauzia Hollnagel, Qianqian Zhao, Nicole Bennett, Veena A. Nair, Eric E. Adelman, Vivek Prabhakaran, and et al. 2025. "Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window" Journal of Clinical Medicine 14, no. 15: 5556. https://doi.org/10.3390/jcm14155556
APA StyleConstantakis, J., Steiner, Q., Reher, T., Choi, T., Hollnagel, F., Zhao, Q., Bennett, N., Nair, V. A., Adelman, E. E., Prabhakaran, V., Aagard-Kienitz, B., & Famakin, B. (2025). Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window. Journal of Clinical Medicine, 14(15), 5556. https://doi.org/10.3390/jcm14155556